This blog post is an excerpt from out latest report Exploring the Impact of COVID-19 on Private Markets Real Estate: Trends in Industrial, Office, Multifamily, and Retail.
Atlas Venture is a Cambridge, MA based early stage venture capital firm focused on biotech. The firm invests exclusively in the therapeutics space within biotech where they are focused on venture creation. We spoke with Kristen Margeson, senior director of IR and marketing at Atlas to learn more about how the firm successfully uses TopQ in their fundraising and investor relations efforts.
In late August, eVestment Private Markets hosted a virtual panel with two LP investors about adapting to digital due diligence. During the conversation, one of the investors had this to say about the remote environment the industry is now operating in, “What’s been a challenge is not having informal interactions, not having AGMs where you can have those longer informal conversations with your managers, and your peers – the exchange of ideas is not as strong at the moment.”
LPs are increasingly focused on the quantitative side of GP value creation during due diligence – looking to validate claims and understand portfolio strategies with data. But are GPs using quantitative data to their advantage to evidence their value-add strengths in their pitch decks and presentations, to go beyond mere claims?
CFOs and COOs in the private markets are acutely aware of the challenges and stiff competition facing their firms today. They have the unenviable role of leading in-house initiatives that create operational excellence and drive success. In many cases this means that they are responsible for thinking critically about firm practices and processes to identify areas in need of innovation and improvements.
Members of the private markets teams from Aberdeen Standard Investments and APG Asset Management recently joined eVestment Private Markets for a discussion about how their due diligence processes have changed in the last few months, and the challenges and opportunities the crisis has presented.
Simply put, portfolio performance data is a GP’s most valuable asset. It is their record of achievement, their recipe for future success, and their best fundraising tool, all in one. That is why it is unfathomable that most GPs are still relying solely on spreadsheets as their primary tool for collecting, managing, and analyzing their performance data.
Graeme Faulds, Director of Product at eVestment Private Markets sits down with Nasdaq’s Jill Malandrino to discuss how the COVID-19 pandemic has affected private equity fundraising in 2020. Here are three key takeaways from the segment.
This blog post highlights how data-driven investors like New Mexico PERA can leverage TopQ+ to enhance their portfolio analytics for more effective manager due diligence.
Works with hundreds of GPs and LPs during their respective fundraising and fund investing processes has given eVestment Private Markets a unique perspective on both sides of the equation, and in today’s volatile fundraising environment, this insight is more important than ever. We’ve distilled some of these insights into three best practices for private equity investor relations professionals to maximize their chances of an efficient and successful fundraise.